Clinical effect of pegylated interferon in combination with ribavirin in the retreatment of previous nonresponders or relapsers of chronic hepatitis C

Chen XiaoYun; Zhang YongHong; Ma LiNa; Jin Yi; Yu HaiBin; Liu YaLi; Zhang XiaoDan; Guo DanDan; Xu YingXia; Zheng YanHong; Ma Bing; Chen XinYue

Issue 12

Dec. 2011

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(12): 1291-1295

PDF( 1144 KB)

Clinical effect of pegylated interferon in combination with ribavirin in the retreatment of previous nonresponders or relapsers of chronic hepatitis C

Research funding:

Published Date: 2011-12-20

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Jialu WANG, Deyang XI, Xuebing YAN, Fang JI, Chunyang LI. Predictors of HBsAg clearance in HBeAg-negative chronic hepatitis B patients treated with pegylated interferon α-2b and the construction of a nomogram model[J]. Journal of Clinical Hepatology, 2023, 39(12): 2809-2816. doi: 10.3969/j.issn.1001-5256.2023.12.010
[2]	Xu JinFeng, Zhang XiaoHui, Liu YaLi, Zhang Jing. Influencing factors for hemolytic anemia in patients with chronic hepatitis C treated by ribavirin combined with pegylated interferon-α[J]. Journal of Clinical Hepatology, 2019, 35(2): 319-322. doi: 10.3969/j.issn.1001-5256.2019.02.015
[4]	You ChunFang, Zhou LiMin, Deng Wei. Correlation between serum ferritin level and antiviral effect of pegylated interferon in chronic hepatitis C patients with genotype 1b[J]. Journal of Clinical Hepatology, 2017, 33(9): 1713-1716. doi: 10.3969/j.issn.1001-5256.2017.09.016
[5]	Chen XiaoYun, Zheng YanHong, Jin Yi, Yu HaiBin, Ma LiNa, Chen XinYue. Correlation between routine blood test results and antiviral effect in patients with refractory chronic hepatitis C treated with pegylated interferon-α[J]. Journal of Clinical Hepatology, 2016, 32(7): 1319-1322. doi: 10.3969/j.issn.1001-5256.2016.07.021
[6]	Zhang Yu, Cao Ying, Zhang RenWen, Zhang XiaXia, Lu HaiYing, Wu ChiHong, Huo Na, Yu Min, Liu Dan, Xu XiaoYuan. Natural resistance mutations to direct- acting antiviral agents in interferon / ribavirin treatment- experienced and treatment- nave patients with chronic hepatitis C in Beijing,China[J]. Journal of Clinical Hepatology, 2016, 32(4): 711-715. doi: 10.3969/j.issn.1001-5256.2016.04.020
[8]	Lin Wei, Si JianLin, Zhang Jian, Maimaitijiang·Wubuliaishan, Hu ZhiMing, Li DongZeng, Geng Nan. Pegylated interferon alpha-2a combined with ribavirin for chronic hepatitis C: a clinical analysis of 160 patients of Uygur nationality or Han nationality[J]. Journal of Clinical Hepatology, 2015, 31(11): 1831-1836. doi: 10.3969/j.issn.1001-5256.2015.11.015
[9]	Sun JianMin. Efficacy of low-dose interferon α-1b combined with ribavirin and thymosin α1 versus standard treatment for chronic hepatitis C: a comparative study [J]. Journal of Clinical Hepatology, 2015, 31(1): 107-109. doi: 10.3969/j.issn.1001-5256.2015.01.023
[10]	Cai ShaoPing, Zhang WenJin, He WeiPing, Fan ZhenPing, Ji YingJie. Efficacy and safety of interferon plus ribavirin in elderly patients with chronic hepatitis C: report of 4 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 69-71. doi: 10.3969/j.issn.1001-5256.2014.01.019
[11]	Wang TingTing, Jiang YingAn, Yang LiHua, Zhou ZhenDong. Efficacy and safety of pegylated interferon in patients with chronic hepatitis C in China: meta- analysis[J]. Journal of Clinical Hepatology, 2013, 29(11): 824-827. doi: 10.3969/j.issn.1001-5256.2013.10.006
[12]	Zhao XiaoLing, Zhang YongGang. Clinical efficacy of ribavirin combined with different doses of interferon α- 2b in patients with chronic hepatitis C genotypes 2 and 3[J]. Journal of Clinical Hepatology, 2013, 29(10): 780-783. doi: 10.3969/j.issn.1001-5256.2013.10.014
[13]	Zhang SuMei, Xie YuMei, Zhang Ying, Guo YongHong, Wei Xin, Jiang Na, Zhou Yun, Jia ZhanSheng. Potential of G-CSF supplementation to counter the neutrophil effects of standard PEG-IFNα plus ribavirin combination therapy for treating HCV-related cirrhosis [J]. Journal of Clinical Hepatology, 2013, 29(5): 348-351.
[14]	Wei Xin, Xie YuMei, Chen Lin, Pan Lei, Hao ChunQiu, Wang JiuPing, Bai XueFan, Jia ZhanSheng. Antiviral therapy with pegylated interferon alpha-2a plus ribavirin in patients with HCV related cirrhosis and to establish the grading for standard therapy[J]. Journal of Clinical Hepatology, 2011, 27(1): 89-92.
[15]	Hao KunYan, He ZhangLun, Yu LeCheng, Sheng YunFeng, Wang MaoRong. Rhabdomyolysis during the antiviral therapy against chronic hepatitis C with the combination of interferon and ribavirin:a case report[J]. Journal of Clinical Hepatology, 2011, 27(6): 654-655.
[16]	Zhu Yan, Mao Qing, Zhang ZhangJiang, Sun Wei, Hu YaJun, Tan ChaoXia, Wang XiaoHong. Retreatment with pegylated interferon alpha-2a/2b and ribavirin in previous relapsers with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2011, 27(1): 86-88.
[17]	Zheng YingYing, Fan XiaoHong, Wang LiFen, Tian Di, Huo Na, Lu HaiYing, Wu ChiHong, Xu XiaoYuan, Wei Lai. Efficacy and side effects of PEG-IFNα-2a plus ribavirin on elderly patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2011, 27(8): 821-823.
[18]	Jiang XueQiang, Zou XiaoJing, Tian DeYing. Virological response of chronic hepatitis C treated with peg-interferon α-2a and Ribavirin[J]. Journal of Clinical Hepatology, 2011, 27(4): 417-419.
[19]	Zhao Ping, Wang JiangBin, Jiao Jian. Response to PEG-IFN α-2a by chronic hepatitis C patients with autoimmune features[J]. Journal of Clinical Hepatology, 2010, 26(4): 374-376.
[20]	Jiao Jian, Wang JiangBin. Study on the response to combined α-IFN, ribavilin and thymosin α1 for different types HCV infection and HCV-HBV coinfection[J]. Journal of Clinical Hepatology, 2004, 20(5): 273-274.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2602) PDF downloads(609)

Clinical effect of pegylated interferon in combination with ribavirin in the retreatment of previous nonresponders or relapsers of chronic hepatitis C

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical effect of pegylated interferon in combination with ribavirin in the retreatment of previous nonresponders or relapsers of chronic hepatitis C

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content